Financials

  • Market Capitalization 127.86 B
  • Employee 56 K
  • Founded N/A
  • CEO Kevin A. Lobo
  • Website www.stryker.com
  • Headquarter Michigan, United States
  • FIGI BBG000DN7P92
  • Industry Medical Devices
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
38.03
Price to sales ratio
5.03
Dividends per share
0.88
Dividend yield %
1.05

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
93
ABT
Abbott Laboratories Common Stock
92.12 USD-1.91%-5.68%+2.79%-30.20%160.46 B USD
144
MDT
Medtronic plc. Ordinary Shares
83.76 USD-0.11%+0.13%+4.28%-10.73%107.22 B USD
253
BSX
Boston Scientific Corporation Common Stock
44.66 USD-0.25%-1.46%-5.84%-56.50%66.38 B USD
299
MDLN
Medline Inc. - Class A common stock
40.82 USD-0.54%-5.05%+14.02%+16.63%53.62 B USD

Frequently asked questions about Stryker Corporation Common Stock

What is the Stryker Corporation Common Stock stock price today?

The current price of Stryker Corporation Common Stock (SYK) is 333.53. Over the past 24 hours, the stock has changed by +1.15%. Follow the SYK chart for real-time price dynamics.

What is the stock ticker of Stryker Corporation Common Stock?

Stryker Corporation Common Stock trades under the ticker SYK. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Stryker Corporation Common Stock stock going up?

SYK has changed by +1.98% over the last week, +8.26% over the last month, and -13.93% over the last year. Review the chart to see whether the current move is part of a broader trend.

Does Stryker Corporation Common Stock release financial reports?

Yes. You can track Stryker Corporation Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

What was Stryker Corporation Common Stock net income for the last quarter?

Stryker Corporation Common Stock reported net income of 745 M for the last quarter. The previous quarter showed 849 M, which means net income changed by -12.25%.

How many employees does Stryker Corporation Common Stock have?

As of the latest available data, Stryker Corporation Common Stock has 56 K employees. Workforce size can provide additional context about the company's scale and operations.

What is Stryker Corporation Common Stock EBITDA?

Stryker Corporation Common Stock EBITDA is 1.33 B, and its EBITDA margin is 22.14%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

How can I buy Stryker Corporation Common Stock stock?

You can buy Stryker Corporation Common Stock (SYK) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Stryker Corporation Common Stock stock?

Investing in Stryker Corporation Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SYK chart and related analysis on metatrader.com as part of your research.

Stryker Corporation Common Stock

Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000.

News